Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Diverio

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Blood|August 1, 1997
Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cellsL Benedetti, A A Levin, B M Scicchitano, et al.
Leukemia|March 17, 2000
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patientsM Mancini, M Cedrone, D Diverio, et al.
Blood|September 25, 1999
Therapy of molecular relapse in acute promyelocytic leukemiaF Lo Coco, D Diverio, G Avvisati, et al.
Blood|March 1, 1996
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminaseL Benedetti, F Grignani, B M Scicchitano, et al.
Blood|September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion proteinC Nervi, F F Ferrara, M Fanelli, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia|June 1, 2002
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?M Breccia, M C Petti, A M Testi, et al.
Blood|July 29, 1998
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" TrialD Diverio, V Rossi, G Avvisati, et al.
Leukemia|March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsP Gorello, G Cazzaniga, F Alberti, et al.
Oncogene|September 15, 2009
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytesS Careccia, S Mainardi, A Pelosi, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Blood|August 1, 1997
Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cellsL Benedetti, A A Levin, B M Scicchitano, et al.
Leukemia|March 17, 2000
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patientsM Mancini, M Cedrone, D Diverio, et al.
Blood|September 25, 1999
Therapy of molecular relapse in acute promyelocytic leukemiaF Lo Coco, D Diverio, G Avvisati, et al.
Blood|March 1, 1996
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminaseL Benedetti, F Grignani, B M Scicchitano, et al.
Blood|September 25, 1998
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion proteinC Nervi, F F Ferrara, M Fanelli, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia|June 1, 2002
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?M Breccia, M C Petti, A M Testi, et al.
Blood|July 29, 1998
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" TrialD Diverio, V Rossi, G Avvisati, et al.
Leukemia|March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsP Gorello, G Cazzaniga, F Alberti, et al.
Oncogene|September 15, 2009
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytesS Careccia, S Mainardi, A Pelosi, et al.
Pageof 7